Diampa LT 10mg+5mg Tablet – Dual Therapy with Empagliflozin 10mg & Linagliptin 5mg for Type 2 Diabetes
Diampa LT 10mg+5mg Tablet – Dual Therapy with Empagliflozin 10mg & Linagliptin 5mg for Type 2 Diabetes
Diampa LT 10mg+5mg Tablet – Dual Therapy with Empagliflozin 10mg & Linagliptin 5mg for Type 2 Diabetes
Description
Diampa LT 10mg+5mg Tablet – Smart SGLT2 + DPP-4 Combination for Better Blood Sugar Control
Diampa LT 10mg+5mg Tablet combines Empagliflozin 10mg (SGLT2 inhibitor) and Linagliptin 5mg (DPP-4 inhibitor) in one convenient tablet to deliver powerful dual-action control for adults with type 2 diabetes. Empagliflozin removes excess glucose through urine while Linagliptin boosts natural insulin release and reduces glucagon levels. This fixed-dose combination provides significant HbA1c reduction, offers cardiovascular and kidney protection, supports modest weight loss, and comes with a low risk of hypoglycemia – all in a single daily dose.
